$2.5T
Total marketcap
$76.65B
Total volume
BTC 50.91%     ETH 15.11%
Dominance

Coloplast A/S 0QBO.IL Stock

0 DKK {{ price }} 0.000000% {{change_pct}}%
Exchange
IOB
Market Cap
212.57B DKK
LOW - HIGH [24H]
0.0000 - 0.0000 DKK
VOLUME [24H]
18.25K DKK
{{ volume }}
P/E Ratio
40.85
Earnings per share
22.5 DKK

Coloplast A/S Price Chart

Coloplast A/S 0QBO.IL Financial and Trading Overview

Coloplast A/S stock price 0.0000 DKK
Previous Close 848.3 DKK
Open 0 DKK
Bid 0 DKK x 0
Ask 0 DKK x 0
Day's Range 0 - 0 DKK
52 Week Range 0 - 991.8 DKK
Volume 16.01K DKK
Avg. Volume 53.23K DKK
Market Cap 180.32B DKK
Beta (5Y Monthly) 0.283908
PE Ratio (TTM) 37.212254
EPS (TTM) 22.5 DKK
Forward Dividend & Yield 20 (2.31%)
Ex-Dividend Date May 15, 2023
1y Target Est N/A

0QBO.IL Valuation Measures

Enterprise Value 200.81B DKK
Trailing P/E 37.212254
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 7.4900494
Price/Book (mrq) 25.677183
Enterprise Value/Revenue 8.341
Enterprise Value/EBITDA 25.838

Trading Information

Coloplast A/S Stock Price History

Beta (5Y Monthly) 0.283908
52-Week Change 12.56%
S&P500 52-Week Change 20.43%
52 Week High 991.8 DKK
52 Week Low 0 DKK
50-Day Moving Average 913.75 DKK
200-Day Moving Average 851.12 DKK

0QBO.IL Share Statistics

Avg. Volume (3 month) 53.23K DKK
Avg. Daily Volume (10-Days) 30.97K DKK
Shares Outstanding 194.31M
Float 130.82M
Short Ratio N/A
% Held by Insiders 35.90%
% Held by Institutions 26.33%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 20
Trailing Annual Dividend Yield 2.35%
5 Year Average Dividend Yield N/A
Payout Ratio 0.885
Last Split Factor 5:1

Financial Highlights

Fiscal Year

Fiscal Year Ends September 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End September 30, 2023

Profitability

Profit Margin 19.94%
Operating Margin (ttm) 29.19%
Gross Margin 68.08%
EBITDA Margin 32.28%

Management Effectiveness

Return on Assets (ttm) 12.46%
Return on Equity (ttm) 67.11%

Income Statement

Revenue (ttm) 24.07B DKK
Revenue Per Share (ttm) 113.37 DKK
Quarterly Revenue Growth (yoy) 10.19%
Gross Profit (ttm) 15.53B DKK
EBITDA 7.77B DKK
Net Income Avi to Common (ttm) 4.8B DKK
Diluted EPS (ttm) 22.85
Quarterly Earnings Growth (yoy) 17.89%

Balance Sheet

Total Cash (mrq) 644M DKK
Total Cash Per Share (mrq) 3.03 DKK
Total Debt (mrq) 21.65B DKK
Total Debt/Equity (mrq) 307.76 DKK
Current Ratio (mrq) 0.988
Book Value Per Share (mrq) 33.115

Cash Flow Statement

Operating Cash Flow (ttm) 4.89B DKK
Levered Free Cash Flow (ttm) 3.36B DKK

Profile of Coloplast A/S

Country United Kingdom
State N/A
City Humlebæk
Address Holtedam 1-3
ZIP 3050
Phone 45 49 11 11 11
Website https://www.coloplast.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 14973

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Q&A For Coloplast A/S Stock

What is a current 0QBO.IL stock price?

Coloplast A/S 0QBO.IL stock price today per share is 0.0000 DKK.

How to purchase Coloplast A/S stock?

You can buy 0QBO.IL shares on the IOB exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Coloplast A/S?

The stock symbol or ticker of Coloplast A/S is 0QBO.IL.

Which industry does the Coloplast A/S company belong to?

The Coloplast A/S industry is Medical Instruments & Supplies.

How many shares does Coloplast A/S have in circulation?

The max supply of Coloplast A/S shares is 0.

What is Coloplast A/S Price to Earnings Ratio (PE Ratio)?

Coloplast A/S PE Ratio is 40.85931800 now.

What was Coloplast A/S earnings per share over the trailing 12 months (TTM)?

Coloplast A/S EPS is 22.5 DKK over the trailing 12 months.

Which sector does the Coloplast A/S company belong to?

The Coloplast A/S sector is Healthcare.